Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - Protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells

Cellular Signalling

Volumn 26, Issue 8, 2014, Pages 1725-1734

  Mandal, Tapashi ^a   Bhowmik, Arijit ^a   Chatterjee, Anirban ^a   Chatterjee, Uttara ^b   Chatterjee, Sandip ^b   Ghosh, Mrinal Kanti ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Park Clinic   (India)

Author keywords

CK2; Glioma; PP2A

Indexed keywords

CASEIN KINASE II; CYCLIN D1; MUTANT PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN BCL XL; SERINE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TYROSINE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN BCL X; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER CELL; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; ENZYME INHIBITION; ENZYME SUBUNIT; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TUMOR CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL TRANSFORMATION; DRUG EFFECTS; GENETICS; GLIOMA; HEK293 CELL LINE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BCL-X PROTEIN; BRAIN NEOPLASMS; CASEIN KINASE II; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; GLIOMA; HEK293 CELLS; HUMANS; OKADAIC ACID; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; SERINE; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84899991135     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.04.003     Document Type: Article

References (56)

1. Ohgaki H., Kleihues P. Cancer Sci. 2009, 100:2235-2241.
2. Rao R.D., James C.D. Semin. Oncol. 2004, 31:595-604.
3. Ji H., Lu Z. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2013, 19:6335-6337.
4. Boldyreff B., Mietens U., Issinger O.G. FEBS Lett. 1996, 379:153-156.
5. Montenarh M. Cell Tissue Res. 2010, 342:139-146.
6. Cozza G., Pinna L.A., Moro S. Curr. Med. Chem. 2013, 20:671-693.
7. Dixit D., Sharma V., Ghosh S., Mehta V.S., Sen E. Cell Death Dis. 2012, 3:e271.
8. Prudent R., Moucadel V., Nguyen C.-H., Barette C., Schmidt F., Florent J.-C., et al. Cancer Res. 2010, 70:9865-9874.
9. Robe P. Int. J. Oncol. 2012, 776-782.
10. Ji H., Wang J., Nika H., Hawke D., Keezer S., Ge Q., et al. Mol. Cell 2009, 36:547-559.
11. Zheng Y., Qin H., Frank S.J., Deng L., Litchfield D.W., Tefferi A., et al. Blood 2011, 118:156-166.
12. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., et al. Cell 1999, 98:295-303.
13. Priester M., Copanaki E., Vafaizadeh V., Hensel S., Bernreuther C., Glatzel M., et al. Neurosci. Oncol. 2013, 15:840-852.
14. Kohsaka S., Wang L., Yachi K., Mahabir R., Narita T., Itoh T., et al. Mol. Cancer Ther. 2012, 11:1289-1299.
15. Rahaman S.O., Harbor P.C., Chernova O., Barnet G.H., Vogelbaum M.A., Haque S.J. Oncogene 2002, 21:8404-8413.
16. Li C.-J., Li Y.-C., Zhang D.-R., Pan J.-H. J. Cancer Res. Ther. 2013, 9:S67-S73. (Suppl.).
17. Wei X., Wang G., Li W., Hu X., Huang Q., Xu K., et al. Oncol. Rep. 2014, 31:335-341.
18. Brantley E.C., Nabors L.B., Gillespie G.Y., Choi Y.-H., Palmer C.A., Harrison K., et al. Clin. Cancer Res. 2008, 14:4694-4704.
19. Ghosh M.K., Sharma P., Harbor P.C., Rahaman S.O., Haque S.J. Oncogene 2005, 24:7290-7300.
20. Chatterjee A., Chatterjee U., Ghosh M.K. Cell Death Dis. 2013, 4:e543.
21. Guturi K.K.N., Mandal T., Chatterjee A., Sarkar M., Bhattacharya S., Chatterjee U., et al. J. Biol. Chem. 2012, 287:18287-18296.
22. Paul I., Ahmed S.F., Bhowmik A., Deb S., Ghosh M.K. Oncogene 2013, 32:1284-1295.
23. Ahmed S.F., Deb S., Paul I., Chatterjee A., Mandal T., Chatterjee U., et al. J. Biol. Chem. 2012, 287:15996-16006.
24. Schaefer L.K., Ren Z., Fuller G.N., Schaefer T.S. Oncogene 2002, 21:2058-2065.
25. Hériché J.K., Lebrin F., Rabilloud T., Leroy D., Chambaz E.M., Goldberg Y. Science 1997, 276:952-955.
26. Togi S., Kamitani S., Kawakami S., Ikeda O., Muromoto R., Nanbo A., et al. Biochem. Biophys. Res. Commun. 2009, 379:616-620.
27. Woetmann A., Nielsen M., Christensen S.T., Brockdorff J., Kaltoft K., Engel A.M., et al. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10620-10625.
28. Lu Y., Fukuyama S., Yoshida R., Kobayashi T., Saeki K., Shiraishi H., et al. J. Biol. Chem. 2006, 281:36683-36690.
29. Bromberg J. J. Clin. Invest. 2002, 109:1139-1142.
30. Levy D.E., Lee C. J. Clin. Invest. 2002, 109:1143-1148.
31. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.-H., Yang Y.M., et al. FASEB J. 2005, 19:1296-1298.
32. Niu G., Wright K.L., Huang M., Song L., Huara E., Turkson J., et al. Oncogene 2002, 21:2000-2008.
33. Dechow T.N., Pedranzini L., Leitch A., Leslie K., Gerald W.L., Linkov I., et al. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10602-10607.
34. Song Y., Qian L., Song S., Chen L., Zhang Y., Yuan G., et al. Mol. Immunol. 2008, 45:137-143.
35. Hanahan D., Weinberg R.A. Cell 2011, 144:646-674.
36. Bowman T., Garcia R., Turkson J., Jove R. Oncogene 2000, 19:2474-2488.
37. Chung J., Uchida E., Grammer T.C., Blenis J. Mol. Cell. Biol. 1997, 17:6508-6516.
38. Decker T., Kovarik P. Oncogene 2000, 19:2628-2637.
39. Jain N., Zhang T., Kee W.H., Li W., Cao X. J. Biol. Chem. 1999, 274:24392-24400.
40. Yokogami K., Wakisaka S., Avruch J., Reeves S.A. Curr. Biol. CB. 2000, 10:47-50.
41. Wakahara R., Kunimoto H., Tanino K., Kojima H., Inoue A., Shintaku H., et al. Genes Cells. 2012, 17:132-145.
42. Aznar S., Valeron P.F., del Rincon S.V., Perez L.F., Perona R., Lacal J.C. Mol. Biol. Cell 2001, 12:3282-3294.
43. Wen Z., Zhong Z., Darnell J.E. Cell 1995, 82:241-250.
44. Wen Z., Darnell J.E. Nucleic Acids Res. 1997, 25:2062-2067.
45. Kim D.J., Chan K.S., Sano S., Digiovanni J. Mol. Carcinog. 2007, 46:725-731.
46. Hazan-Halevy I., Harris D., Liu Z., Liu J., Li P., Chen X., et al. Blood 2010, 115:2852-2863.
47. Lee H., Herrmann A., Deng J.-H., Kujawski M., Niu G., Li Z., et al. Cancer Cell 2009, 15:283-293.
48. Andersson C.X., Sopasakis V.R., Wallerstedt E., Smith U. J. Biol. Chem. 2007, 282:9430-9435.
49. Shi X., Zhang H., Paddon H., Lee G., Cao X., Pelech S. Biochemistry (Mosc) 2006, 45:5857-5867.
50. Westermarck J., Hahn W.C. Trends Mol. Med. 2008, 14:152-160.
51. Neviani P., Santhanam R., Trotta R., Notari M., Blaser B.W., Liu S., et al. Cancer Cell 2005, 8:355-368.
52. Junttila M.R., Puustinen P., Niemelä M., Ahola R., Arnold H., Böttzauw T., et al. Cell 2007, 130:51-62.
53. Mumby M. Cell 2007, 130:21-24.
54. Zhao M., Jiang B., Gao F.-H. Curr. Med. Chem. 2011, 18:4012-4018.
55. Madoux F., Koenig M., Nelson E., Chowdhury S., Cameron M., Mercer B., et al. Probe Rep. NIH Mol. Libr. Program 2010, National Center for Biotechnology Information (US), Bethesda (MD).
56. Walker S.R., Xiang M., Frank D.A. Mol. Cell. Endocrinol. 2014, 382:616-621.